Veille Pharma
Follow
20.2K views | +0 today
Veille Pharma
Chargé d'affaires chez Patientsworld. Mes posts n'engagent que moi.
Your new post is loading...
Your new post is loading...
Scooped by Alexandre DUBOIS
Scoop.it!

Big pharma’s changing business model: Inviting academia to take the lead — Vector

Big pharma’s changing business model: Inviting academia to take the lead — Vector | Veille Pharma | Scoop.it

In almost every conversation I have these days with potential industry partners, I hear what seems to be the new buzz phrase: “Clear path to clinic.” A molecule with a “clear path to clinic” can become a medicine quickly, by virtue of a well-defined patient population, clear endpoints for clinical trials and measurable biomarkers.

more...
No comment yet.
Scooped by Alexandre DUBOIS
Scoop.it!

Des cellules «tueuses» au secours d'une leucémie 

Des cellules «tueuses» au secours d'une leucémie  | Veille Pharma | Scoop.it

Deux patients atteints de la forme la plus fréquente de leucémie, traités avec leurs propres cellules génétiquement modifiées, sont en rémission complète avec un recul d'un an.

more...
No comment yet.
Scooped by Alexandre DUBOIS
Scoop.it!

Drugmaker Glaxo creates dragon culture

In 2008, the company organized its scientists into small teams, some with just a handful of staff, and set them to work on different diseases. At the time, every one of these drug performance units (DPUs) had to plead its case for a slice of Glaxo’s four-billion-pound research and development budget. Three years on and each of the 38 DPUs is having to plead its case for another dollop of funding to 2014.

more...
No comment yet.
Scooped by Alexandre DUBOIS
Scoop.it!

Article > US biopharma: 198 arthritis medicines now in R&D

Article > US biopharma: 198 arthritis medicines now in R&D | Veille Pharma | Scoop.it
US biopharmaceutical companies have 198 new medicines currently in R&D which can potentially help the more than 50 million Americans who have at least one of the 100 different musculoskeletal disorders, including arthritis.
more...
No comment yet.